PharmEvo bags global award for anaemia breakthrough

A locally-invented iron supplement by a Pakistani pharmaceutical firm has clinched an international award at the 6th Annual Global Generics and Biosimilars 2019 ceremony in Frankfurt, Germany after it was declared as the best intervention to overcome iron-deficiency anemia among women and children.

Iron-deficiency anemia among women and children is around 50 percent and is the leading cause of stunted growth, malnourishment and serious health issues among Pakistani children while as many as 45 to 50 percent Pakistani women of reproductive age (15-49 years) are also anemic due to iron deficiency.

The 'Orodispersible powder with encapsulated iron,' invented and prepared by Pakistani Pharmaceutical firm PharmEvo was declared as the most innovating product to combat iron-deficiency anemia among women and children during the CPhI Pharma Awards at Frankfurt Germany last month and the company was awarded the Business Development of the Year Award at the international acclaimed exhibition and awards ceremony.

In addition to clinching the top award, the Ferfer oral powder was also short-listed for the Value Added Medicine Initiative of the Year Award after it was found to be most fast-acting product that can help alleviate iron deficiency anemia among women and children.

Felicitating his team of experts for the development and marketing of an internationally-acclaimed medicine, Managing Director of the local pharmaceutical firm PharmEvo, Haroon Qasim said the conferment of prestigious global award to their firm at the most prestigious pharmaceutical forum in the world was 'proud moment' for entire Pakistan and its pharmaceutical industry.